Corticotropin releasing activity of the new CRF is potentiated several times by vasopressin
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Initially the hypothalamic factor responsible for the release of corticotropin (CRF), was thought to be a simple peptide. More recent work has led to the conclusion that CRF is a multifactorial complex. In 1979 we proposed that vasopressin, much disputed as a CRF candidate, was a major constituent of the complex, interacting with a potentiating the CRF activity of the other component(s). The recent characterization of a 41 residue ovine hypothalamic peptide capable of releasing adrenocorticotropic hormone (ACTH) in a dose-related manner has allowed us to compare its CRF bioactivity with that of vasopressin and simple extracts of the hypothalamus, and to investigate any interaction it may have with vasopressin and other hypothalamic factors in the release of ACTH. We report here that the new CRF is more potent than vasopressin in releasing ACTH. When given simultaneously with vasopressin a fourfold potentiation of CRF activity with steep dose-response characteristics were observed. It also potentiated vasopressin-free hypothalamic extracts, suggesting that a new CRF does not account for all the nonvasopressin portion of the CRF complex.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Their synergistic stimulation of ACTH production and secretion by corticotrope cells could yield a several-fold higher output than due to the action of either one individually (26, 34–41, 43–47).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, it has been indicated that both CRH and AVP act on their own receptors (28–32) on corticotrope cells in anterior pituitary to stimulate adrenocorticotropic hormone (ACTH) production and release with different (26, 33–41) or even similar potencies (42).”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Namely, both in human (39, 43–47, 55) and in rat (26, 36–38, 40, 41), CRH reaction pathway is considered to be dominant in pituitary-adrenal regulation.”
From Influence of arginine vasopressin on the ultradian dynamics of Hypothalamic-Pituitary-Adrenal axis (2022) · cites this paper as [36]
In the citing paper
“Corticotropin-releasing hormone and AVP interact at the level of the anterior pituitary (16)”
From Progesterone does not alter osmotic regulation of AVP (2001) · cites this paper as [16]
In the citing paper
“Furthermore, VP stimulates adrenocorticotropin hormone release through the activation of pituitary V1bR [10,11].”
From Vasopressin and hydration play a major role in the development of glucose intolerance and hepatic steatosis in obese rats (2015) · cites this paper as [10]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
VALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Schally, A. V., Arimura, A., & Kastin, A. J. (1973) · Science · doi:10.1126/science.179.4071.341 · Cited by 572
Frontiers in Neuroendocrinology
Ball, J. B. (1975) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-197501000-00019 · Cited by 426
FRONTIERS IN NEUROENDOCRINOLOGY
Kennedy, G. C. (1970) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.33.5.719 · Cited by 357
Corticotrophin releasing factor may be modulated vasopressin
GILLIES, G., & LOWRY, P. (1979) · Nature · doi:10.1038/278463a0 · Cited by 174
Self-citationHypothalamic Releasing Factors
Burgus, R. C., & Guillemin, R. (1970) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.39.070170.002435 · Cited by 129
Gillies, G. E., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-521 · Cited by 106
Self-citationZimmerman, E. A., Stillman, M. A., Recht, L. D., Antunes, J. L. F., Carmel, P. W., & Goldsmith, P. C. (1977) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1977.tb41872.x · Cited by 97
Gillies, G. E., Greidanus, T. B. V. W., & Lowry, P. J. (1978) · Endocrinology · doi:10.1210/endo-103-2-528 · Cited by 60
Self-citation
Research works printed but not linked: 5
- Royce, P. C. & Sayers, G. Proc. Soc. exp. Biol. Med. 142, 842–845 (1960).
- Gillies, G. & Lowry, P. J. in Interactions within the Brain-Pituitary-Adrenocortical System (eds Jones, Gilham, Dallman & Chattopadhyay) 51–61 (Academic, New York, 1979).
- Sokol, H. W. & Zimmerman, E. A. Ann. N.Y. Acad. Sci. (in the press).
- Zimmerman, E. A. in Frontiers of Neuroendocrinology Vol. 4 (eds Martini, L. & Ganong, W. F.) 25–62 (Raven, New York, 1976).
- Baertischi, A. in Neuroendocrinology of Vasopressin, Corticoliberin and Opiomelanocortin (eds Baertischi, A. & Driefuss, J.-J.) (Academic, London, in the press).
Cited by
Items 601–700 of 971
Gene Regulation System of Vasopressin and Corticotoropin-Releasing Hormone
Yoshida, M. (2008) · Gene Regulation and Systems Biology · doi:10.4137/grsb.s424 · Cited by 24
“Compared with CRH, vasopressin itself has a weak ability of upregulating the ACTH secretion; however, it markedly potentiates the effect of CRH (Gilles et al. 1982; DeBold et al. 1984; Volpi et al. 2004).”
He, Z., Fernández-Fuente, M., Strom, M., Cheung, L., Robinson, I. C. A. F., & Tissier, P. L. (2010) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2010.02104.x · Cited by 22
Waldherr, M., Nyuyki, K. D., Maloumby, R., Bosch, O. J., & Neumann, I. D. (2009) · Hormones and Behavior · doi:10.1016/j.yhbeh.2009.11.006 · Cited by 22
Hypothalamic-Pituitary-Adrenal Axis
Kyrou, I., & Tsigos, C. (2005) · Springer eBooks · doi:10.1007/3-540-26861-8_3 · Cited by 25
Grinevich, V., Harbuz, M. S., Ma, X., Jessop, D. S., Tilders, F. J. H., Lightman, S. L., & Aguilera, G. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8022 · Cited by 21
Hillhouse, E. W. (1994) · Brain Research · doi:10.1016/0006-8993(94)91799-x · Cited by 23
Korbonits, M., Trainer, P. J., Edwards, R., BESSER, G. M., & Grossman, A. B. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb01889.x · Cited by 20
Stressor-specific increase of vasopressin mRNA in paraventricular hypophysiotrophic neurons
Bartanusz, V., Aubry, J., Steimer, T. J., Baffi, J., & Kiss, J. Z. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90232-1 · Cited by 20
Bond, H., Warne, J. M., & BALMENT, R. J. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.03.014 · Cited by 20
Knepel, W., Przewłocki, R., Nutto, D., & Herz, A. (1985) · Endocrinology · doi:10.1210/endo-117-1-292 · Cited by 20
Catania, A., CANTALAMESSA, L., Orsatti, A., Mosca, G., Minonzio, F., Motta, P., Reschini, E., & Zanussi, C. (1984) · Metabolism · doi:10.1016/0026-0495(84)90151-3 · Cited by 20
Transmembrane signals mediating adrenocorticotropin release from mouse anterior pituitary cells
Castro, M. G., Gusovsky, F., & Loh, Y. P. (1989) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(89)90177-9 · Cited by 20
Grossman, A. B., Delitala, G., Mannelli, M., Al‐Damluji, S., Coy, D. H., & BESSER, G. M. (1986) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1986.tb01708.x · Cited by 21
Maternal serum copeptin concentrations in early- and late-onset pre-eclampsia
Tüten, A., Öncül, M., Kücür, M., İmamoğlu, M., Ekmekçi, Ö. B., Açıkgöz, A. S., Cebe, F. S., Yeşilbaş, C., & Madazlı, R. (2015) · Taiwanese Journal of Obstetrics and Gynecology · doi:10.1016/j.tjog.2013.10.045 · Cited by 22
Stress, Endocrine Manifestations, and Diseases
Chrousos, G. P., Tsigos, C., & Kyrou, I. (2004) · CRC Press eBooks · doi:10.1201/9781420039702.ch6 · Cited by 21
Katoh, K., Yoshida, M., Kobayashi, Y., Onodera, M., Kogusa, K., & Obara, Y. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06206 · Cited by 19
Heterogeneity of Calcium Responses to Secretagogues in Corticotrophs From Male Rats
Romanò, N., McClafferty, H., Walker, J. J., Tissier, P. L., & Shipston, M. J. (2017) · Endocrinology · doi:10.1210/en.2017-00107 · Cited by 20
“The vector was able to transduce ACTHimmunoreactive cells with .95% specificity [Fig.”
BackgroundInfluentialNon‐mammalian Corticotropin Release‐stimulating Peptidesa
Lederis, K. P. (1987) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1987.tb24955.x · Cited by 19
Finn, D. P., Lalies, M. D., Harbuz, M. S., Jessop, D. S., Hudson, A. L., & Nutt, D. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00046-1 · Cited by 19
Przewłocki, R. (1993) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-77540-6_12 · Cited by 20
Pasquier, D. D., Loup, F., Dubois‐Dauphin, M., Dreifuss, J. J., & Tribollet, E. (1991) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1991.tb00270.x · Cited by 19
Functional relations of crab molt-inhibiting hormone and neurohypophysial peptides
Mattson, M. P., & Spaziani, E. (1985) · Peptides · doi:10.1016/0196-9781(85)90166-4 · Cited by 19
Lutz‐Bucher, B., Jeandel, L., Heisler, S., Roberts, J. L., & Koch, B. (1987) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(87)90170-5 · Cited by 19
Vasopressin in the regulation of body functions
Mohr, E., & Richter, D. (1996) · Springer eBooks · doi:10.1007/978-94-009-0083-7_19 · Cited by 19
Reincke, M., LEHMANN, R., Karl, M., MAGIAKOU, A., Chrousos, G. P., & Allolio, B. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb44710.x · Cited by 21
Hypothalamic organization of corticotropin releasing factor (CRF) producing structures
Makara, G. B., Antoni, F. A., Stark, E., & Kárteszi, M. (1984) · Elsevier eBooks · doi:10.1016/b978-0-444-90377-8.50006-5 · Cited by 19
Bronstein, D. M., & Akil, H. (1990) · Neuropeptides · doi:10.1016/0143-4179(90)90027-v · Cited by 21
Livesey, J., Evans, M. J., Mulligan, R., & Donald, R. A. (2000) · Endocrine Research · doi:10.3109/07435800009066179 · Cited by 20
Arginine vasopressin in Cushing's disease
Wittert, G., Donald, R. A., Espiner, E. A., Crock, P., Gilford, E., Boolell, M., & ALFORD, F. P. (1990) · The Lancet · doi:10.1016/0140-6736(90)91063-g · Cited by 18
Herman, J. P., Thomas, G. J., & Gash, D. M. (1986) · Behavioural Brain Research · doi:10.1016/0166-4328(86)90098-7 · Cited by 19
Rose, J. C., Hargrave, B., Dix, P. M., Meis, P. J., LaFave, M., & Torpe, B. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90396-5 · Cited by 18
Patchev, V. K., & Almeida, O. F. X. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb01153.x · Cited by 18
Tomori, N., Suda, T., NAKAGAMI, Y., TOZAWA, F., Sumitomo, T., USHIYAMA, T., Demura, H., & SHIZUME, K. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-1-87 · Cited by 18
Stress, microbiota, and the gut–brain axis in mental and digestive health
Santos, J., Maran, P. L., & Rodríguez‐Urrutia, A. (2025) · Medicina Clínica · doi:10.1016/j.medcli.2024.11.023 · Cited by 24
Central Bombesin Activates the Hypothalamic-Pituitary-Adrenal Axis
Kent, P., Anisman, H., & Merali, Z. (2001) · Neuroendocrinology · doi:10.1159/000054637 · Cited by 18
Værøy, H., Ádori, C., Legrand, R., Lucas, N., Breton, J., Cottard, C., do-Rego, J.-C., Duparc, C., Louiset, E., Lefèbvre, H., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1720008115 · Cited by 17
“This finding is of interest, because hypothalamic vasopressin potentiates corticotropin-releasing hormone-induced ACTH secretion during the stress response (47, 48) and is implicated in sex-dependent regulation of aggressive behavior (49).”
BackgroundCopeptin response to hypoglycemic stress is linked to prolactin activation in children
Drummond, J., Soares, B. S., Pedrosa, W., Vieira, É. L. M., Teixeira, A. L., Christ‐Crain, M., & Ribeiro‐Oliveira, A. (2020) · Pituitary · doi:10.1007/s11102-020-01076-6 · Cited by 18
Volpi, S., Liu, Y., & Aguilera, G. (2006) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.01995 · Cited by 18
“…in parvocellular neurons of the paraventricular nucleus (PVN) of the hypothalamus is an important regulator of pituitary adrenocorticotropin (ACTH) secretion, mainly by potentiating the stimulatory e ff ect of corticotropin releasing hormone (Gillies et al. 1982, Antoni 1993, Aguilera 1994).”
BackgroundKatoh, K., Asari, M., Ishiwata, H., Sasaki, Y., & Obara, Y. (2003) · Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology · doi:10.1016/j.cbpb.2003.10.011 · Cited by 17
Cortisol response to vasopressin in depression
Krahn, D. D., Meller, W. H., Shafer, R. B., & Morley, J. E. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90217-3 · Cited by 17
Aguilera, G., Abou‐Samra, A., Harwood, J. P., & Catt, K. J. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-2064-5_7 · Cited by 17
Antisense oligonucleotides in neuroendocrinology: Enthusiasm and frustration
Neumann, I. D. (1997) · Neurochemistry International · doi:10.1016/s0197-0186(96)00107-6 · Cited by 19
van Woudenberg, A. D., Hol, E. M., & Wiegant, V. M. (1992) · Life Sciences · doi:10.1016/0024-3205(92)90473-3 · Cited by 17
Yang, J., Pan, Y.-J., Yin, Z., Hai, G.-F., Lu, L., Zhao, Y. Y., Wang, D., Wang, H., & Wang, G. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.03.003 · Cited by 17
“ACTH, in turn, potently stimulates the secretion of glucocorticoids (corticosterone in rats and cortisol in humans) from the adrenal cortex (Gillies et al., 1982; Rivier et al., 1984; Antoni, 1993; Aguilera et al., 1994).”
BackgroundVærøy, H., Schneider, F., & Fetissov, S. O. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00872 · Cited by 17
“AVP and CRH are found to co-exist in CRH nerve terminals (65, 66), and together with CRH, AVP strongly potentiates its ACTH-releasing activity (67, 68).”
BackgroundKikuyama, S., Hasunuma, I., & Okada, R. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.111143 · Cited by 16
Okada, R., Yamamoto, K., Hasunuma, I., Asahina, J., & Kikuyama, S. (2016) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2016.08.014 · Cited by 16
Chapter 5 Central vasopressin systems and steroid hormones
Kalsbeek, A., Palmand, I. F., & Buijs, R. M. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39007-1 · Cited by 19
“, 1997) its direction is completely opposite to the previously described and well-known stimulatory effect of VP on ACTH and corticosterone release (Gillies et al., 1982; Rivier and Vale, 1983; Rivier et al., 1984).”
BackgroundHypothalamic-Pituitary-Adrenal Axis in WBN/Kob Rats with Non-lnsulin Dependent Diabetes Mellitus.
Tojo, C., Takao, T., Nishioka, T., Numata, Y., Suemaru, S., & Hashimoto, K. (1996) · Endocrine Journal · doi:10.1507/endocrj.43.233 · Cited by 16
Giussani, D. A., Winter, J. A., Jenkins, S. L., Tame, J. D., Abrams, L. M., Ding, X. Y., & Nathanielsz, P. W. (1998) · Endocrinology · doi:10.1210/endo.139.6.6044 · Cited by 16
“First, the CRH concentrations, measured in late gestation human maternal plasma, are similar to the levels reported in rat hypothalamic portal blood after adrenalectomy (11, 12), and to those capable of stimulating pituitary ACTH release in vitro (13).”
ResultArai, K., & Takebe, K. (1991) · Metabolism · doi:10.1016/0026-0495(91)90135-j · Cited by 16
Distribution and molecular forms of immunoreactive bombesin in the ovine median eminence
Giraud, A. S., Smith, A. L., & Rundle, S. E. (1987) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(87)90180-8 · Cited by 16
de Goeij, D. C. E., BERKENBOSCH, F., & Tilders, F. J. H. (1993) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1993.tb00369.x · Cited by 16
Jun-Ping, L. (1994) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(94)90186-4 · Cited by 16
Effect of oestrogen-dependent vasopressin on HPA axis in the median eminence of female rats
Nishimura, K., Yoshino, K., Sanada, K., Beppu, H., Akiyama, Y., Nishimura, H., Tanaka, K., Sonoda, S., Ueno, H., Yoshimura, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41714-z · Cited by 15
Transcriptional Regulation of Hypothalamic Corticotropin-Releasing Factor Gene
Kageyama, K., & Suda, T. (2010) · Vitamins and hormones · doi:10.1016/s0083-6729(10)82016-3 · Cited by 17
The Placenta is Simply a Neuroendocrine Parasite
Lowry, P. J. (2008) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2008.01737.x · Cited by 15
Self-citationPlasma copeptin and metabolic dysfunction in individuals with bipolar disorder
Mansur, R. B., Rizzo, L. B., Santos, C. M., Asevedo, E. D. M., da Cunha, G. R., Noto, M. N., Pedrini, M., Zeni‐Graiff, M., Cordeiro, Q., McIntyre, R. S., et al. (2017) · Psychiatry and Clinical Neurosciences · doi:10.1111/pcn.12535 · Cited by 16
Physiological/Neurophysiological Mechanisms Involved in the Formation of Stress Responses
Yaribeygi, H., & Sahraei, H. (2018) · Neurophysiology · doi:10.1007/s11062-018-9727-1 · Cited by 16
“In fact, AVP is simply a weak stimulator of ACTH, but it can considerably reinforce the effect of CRF on corticotrophin pituitary cells [50].”
Engler, D. (2007) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 19
Stress and the Reproductive System
Li, X.-F., & O’Byrne, K. T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-397175-3.00036-3 · Cited by 17
The human hypothalamo-neurohypophysial system in health and disease
Swaab, D. F. (1999) · Progress in brain research · doi:10.1016/s0079-6123(08)61594-0 · Cited by 17
Characterization of vasopressin receptor in rat lung
Tahara, A., Tomura, Y., Wada, K., Kusayama, T., Tsukada, J., Ishii, N., Yatsu, T., Uchida, W., & Tanaka, A. (1998) · Neuropeptides · doi:10.1016/s0143-4179(98)90049-x · Cited by 15
Tetrahydroquinoline sulfonamides as vasopressin 1b receptor anatgonists
Scott, J. D., Miller, M. W., Li, S. W., Lin, S., Vaccaro, H. A., Hong, L., Mullins, D. E., Guzzi, M., Weinstein, J., Hodgson, R. A., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.09.050 · Cited by 16
Foppiani, L., Sessarego, P., VALENTI, S., FALIVENE, M. R., CUTTIC, C. M., & Giusti, M. (1996) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1996.tb02133.x · Cited by 16
The Effects of Stress on Autoimmune Disease
Whitacre, C. C., Cummings, S. O., & Griffin, A. C. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-285960-1.50008-3 · Cited by 19
Colao, A., Pivonello, R., Ferone, D., Faggiano, A., Facciolli, G., Somma, C. D., Boudouresque, F., Oliver, C., & Lombardi, G. (1998) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1998.00479.x · Cited by 15
Unno, N., Wu, W. X., Ding, X. Y., Li, C., Hing, W. K. H. M. A., & Nathanielsz, P. W. (1998) · Developmental Brain Research · doi:10.1016/s0165-3806(97)00203-4 · Cited by 15
Herbert, J., & Howes, S. R. (1993) · Peptides · doi:10.1016/0196-9781(93)90022-9 · Cited by 16
Endocrine and Immunological Responses to Acute Stress
BERKENBOSCH, F., Heijnen, C. J., Croiset, G., Revers, C. W. B., BALLIEUX, R. E., Binnekade, R., & Tilders, F. J. H. (1986) · Springer eBooks · doi:10.1007/978-1-4899-0557-4_10 · Cited by 16
Neuroendocrine and behavioral effects of vasopressin in resting and mild stress conditions
Buwalda, B., Nyakas, C. J., Koolhaas, J. M., & Bohus, B. (1993) · Physiology & Behavior · doi:10.1016/0031-9384(93)90307-2 · Cited by 15
Itagaki, E., Ozawa, S., Yamaguchi, S., Ushikawa, K., 輝明, 田., Katahira, H., Takizawa, M., Yoshimoto, K., Murakawa, S., & Ishida, H. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.12.8073 · Cited by 14
“to act in concert with CRH on ACTH secretion (1, 2).”
BackgroundKageyama, K., Tamasawa, N., & Suda, T. (2011) · Stress · doi:10.3109/10253890.2010.536279 · Cited by 17
“CRF and AVP in parvocellular PVN neurons exert synergistic effects on ACTH secretion from the AP (Gillies et al. 1982; Mouri et al. 1993).”
BackgroundWells, S. E., Flavell, D. M., Bisset, G. W., Houston, P. A., Christian, H., Fairhall, K. M., & Robinson, I. C. A. F. (2003) · The Journal of Physiology · doi:10.1111/j.1469-7793.2003.00323.x · Cited by 14
Nephew, B. C., Romero, L. M., & Romero, L. M. (2005) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2005.05.010 · Cited by 14
Itoi, K., Motoike, I. N., Liu, Y., Clokie, S. J. H., Iwasaki, Y., Uchida, K., Sato, T., & Aguilera, G. (2018) · Endocrinology · doi:10.1210/en.2018-00535 · Cited by 16
“The parvocellular AVP is a physiological secretagogue of ACTH in the pituitary, and its secretion is stimulated by stress (4, 5).”
BackgroundInvolvement of multiple protein kinase C isozymes in the ACTH secretory pathway of AtT‐20 cells
McFerran, B. W., MacEwan, D. J., & Guild, S. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb15878.x · Cited by 14
Simonneaux, V., Kozak, R., Arsenijévic, Y., & Pévet, P. (1996) · Regulatory Peptides · doi:10.1016/0167-0115(95)00139-5 · Cited by 14
Stimulation by angiotensins I and II of ACTH release from goldfish pituitary cell columns
Weld, M. M., & Fryer, J. N. (1987) · General and Comparative Endocrinology · doi:10.1016/0016-6480(87)90055-4 · Cited by 14
Evidence for glucocorticoid regulation of the rat vasopressin V1a receptor gene
Watters, J. J., Swank, M. W., Wilkinson, C. W., & Dorsa, D. M. (1996) · Peptides · doi:10.1016/0196-9781(95)02085-3 · Cited by 14
Neuro-endocrine aspects of the dexamethasone suppression test in psychiatry
Lamberts, S. W. J. (1986) · Life Sciences · doi:10.1016/0024-3205(86)90441-8 · Cited by 14
No role of vasopressin in stress-induced ACTH secretion?
Baertschi, A. J., Gähwiler, B. H., Antoni, F. A., Holmes, M. C., & Makara, G. B. (1984) · Nature · doi:10.1038/308085c0 · Cited by 14
Plotsky, P. M., Otto, S., TOYAMA, T. T., & Sutton, S. W. (1990) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1990.tb00394.x · Cited by 14
Vasopressin and Endocrine Function
Hedge, G. A., & Huffman, L. J. (1987) · Springer eBooks · doi:10.1007/978-1-4615-8129-1_11 · Cited by 13
Comparative pharmacology of bovine, human and rat vasopressin receptor isoforms
Andrés, M., Peña, A., Derick, S., Raufaste, D., Trojnar, J., Wiśniewski, K., Trueba, M., Gal, C. S., & Guillon, G. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.08.026 · Cited by 13
Stress, Opioid Peptides, and Their Receptors
Przewłocki, R. (2009) · Elsevier eBooks · doi:10.1016/b978-008088783-8.00008-5 · Cited by 14
Huang, Y.-S., Jiang, J.-W., Wu, G.-C., & Cao, X.-D. (2002) · Acupuncture & Electro-Therapeutics Research · doi:10.3727/036012902816026077 · Cited by 14
In vivo potentiation of corticotropin releasing factor activity by vasopressin analogues
Fischman, A. J., & Moldow, R. L. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90103-6 · Cited by 13
Changes in hypothalamic oxytocin levels during morphine tolerance
Laorden, M. L., Milanés, M. V., Chapleur-Château, M., & Burlet, A. J. (1997) · Neuropeptides · doi:10.1016/s0143-4179(97)90083-4 · Cited by 13
René, P., Grino, M., Viollet, C., Videau, C., Jullian, E. H., Bucchini, D., Epelbaum, J., BERTAGNA, X. Y., & de Keyzer, Y. (2002) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2002.00834.x · Cited by 15
Effect of low amphetamine doses on cardiac responses to emotional stress in aged rats
Nyakas, C. J., Buwalda, B., Luiten, P. G. M., & Bohus, B. (1992) · Neurobiology of Aging · doi:10.1016/0197-4580(92)90019-t · Cited by 15
WHITE, M. C., Adams, E. F., LOIZOU, M., MASHITER, K., & Fahlbusch, R. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb00227.x · Cited by 13
Kovács, K. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39013-7 · Cited by 18
Mimoto, T., Nishioka, T., Asaba, K., Takao, T., & Hashimoto, K. (2001) · Brain Research · doi:10.1016/s0006-8993(01)03184-5 · Cited by 13
Al‐Damluji, S., White, A. E., & Besser, M. (1990) · Endocrinology · doi:10.1210/endo-127-6-2849 · Cited by 13
Vasopressin and vasopressin analogues for treatment of memory disorders in clinical practice
Lecros, J.-J., & Timsit-Berthier, M. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90074-7 · Cited by 13
Molecular and functional mapping of the neuroendocrine hypothalamus: a new era begins
Lee, T. H., Nicolas, J.-C., & Quarta, C. (2024) · Journal of Endocrinological Investigation · doi:10.1007/s40618-024-02411-5 · Cited by 14
“Arginine vaso-pressin (AVP) is present in both magnocellular and parvo-cellular divisions of the PVN [221], and the latter population of AVP is colocalised with CRH [222].”
The vasotocinergic system and its role in the regulation of stress in birds
Kuenzel, W. J., Kang, S. W., & Jurkevich, A. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.10.004 · Cited by 12
Is There a “Final Common Pathway” in the Regulation of ACTH Release?
Whitnall, M. H. (1988) · Advances in experimental medicine and biology · doi:10.1007/978-1-4899-2064-5_11 · Cited by 12
Chapter 27 The vasopressin receptor of corticotroph pituitary cells
René, P., & de Keyzer, Y. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39029-0 · Cited by 15
Metadata
- Authors
- Gillies, G. E., Linton, E. A., & Lowry, P. J.
- Affiliations
- St Bartholomew's Hospital (GB)
- ORCID
- Linton, E. A.
- Venue
- Nature
- Published
- 1982-09
- Volume
- 299
- Issue
- 5881
- Pages
- 355-357
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2088159839
- Cited by
- 965
- References
- 20
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 6 · 2023: 10 · 2022: 12 · 2021: 7 · 2020: 12 · 2019: 16 · 2018: 10 · 2017: 16 · 2016: 20 · 2015: 12 · 2014: 20 · 2013: 16 · 2012: 17
- FWCI
- 12.30
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, vasopressin, hypothalamic neuropeptides, hypothalamic extract, hypothalamic-pituitary-adrenal axis
- MeSH terms
- Adrenocorticotropic Hormone, Animals, Corticotropin-Releasing Hormone, Dose-Response Relationship, Drug, Drug Synergism, Hypothalamus, Vasopressins, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.